Ranolazine

NDC 71610-518 · Aphena Pharma Solutions - Tennessee, LLC

Generic nameRANOLAZINE

Dosage formTABLET, FILM COATED, EXTENDED RELEASE

RouteORAL

Active ingredient(s)RANOLAZINE

Strength500 mg/1

Pharmacologic classAnti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]

Marketing categoryANDA

Packages

71610-518-42 — 1800 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71610-518-42)

71610-518-83 — 3600 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71610-518-83)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

69367-294 — Ranolazine, 70625-206 — RANOLAZINE, 70625-207 — RANOLAZINE, 70756-703 — Ranolazine, 70756-704 — Ranolazine, 70771-1499 — Ranolazine, 70771-1500 — Ranolazine, 71205-867 — Ranolazine, 71205-868 — Ranolazine, 71335-2556 — RANOLAZINE, 71610-971 — RANOLAZINE, 72319-021 — RANOLAZINE, 72319-022 — RANOLAZINE, 72578-064 — Ranolazine, 72578-065 — Ranolazine, 73141-021 — RANOLAZINE, 73141-022 — RANOLAZINE, 77771-423 — RANOLAZINE, 77771-424 — RANOLAZINE, 82804-118 — Ranolazine, +34 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.